Epstein Secrets

ort on Form 10-Q for the quarterly period ended September 30. 2015. to co a Ce3 which are incorporated herein by reference. ca os co a Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these a= >. securities or passed upon the accuracy or adequacy of this prospectus

luding the risk factors incorporated by reference from Part I, Item lA of our most recent Annual Report on Form 10-K, as may be updated by Part II, Item IA of our Quarterly Reports on Form 10-Q and other SEC filings filed after such Annual Report, which are incorporated by reference herein. See "Where Y

the fiscal year ended March 31, 2018 , included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2018 , as filed with the U.S. Securities and Exchange Commission ("SEC"). NOTE 2 — FIELD-FOR-SALE AND DISCONTINUED OPERATIONS Subsequent to the current period's balance sheet date of June 30, 2018 the Company and

iscussed in this report and in the Company's Form 10-K for the year ended March 31, 2018 , including, but not limited to, any discussions in Part I, Item IA, "Risk Factors" (as supplemented by any subsequent disclosures in information the Company files with or furnishes to the SEC from time to time), man

offering price. less the underwriting discount. within 30 days from the date of this prospectus supplement solely to cover over-allotments. None of the Securities and Exchange Commission, any state securities commission, the Registrar of Companies in Bermuda, the Bermuda Monetary Authority or any other regulatory body has approved or

tled "Risk Factors," the accompanying prospectus and the documents incorporated herein by reference (including the risk factors set forth in Part 1, Item IA of our Annual Report on Font 10-K for the year ended December 31, 2015), our financial statements and notes thereto incorporated by reference into t

and • other risks detailed in our Annual Report on Form 10-K for the year ended December 31, 2015 and from time to time in our other filings with the Securities and Exchange Commission ("SEC"). We describe some of these risks and uncertainties in greater detail under the caption "Risk Factors" above, beginning on page 6 of the acc

and the applicable prospectus supplement. You should consider the risks, uncertainties and assumptions discussed under the caption "Risk Factors" in Item IA of our Annual Report, which is incorporated by reference in this prospectus. If any of the events or circumstances described as risks actually occur

"Risk Factors" beginning on page S•6 to read about factors you should consider before buying the depositary 'S a. shares. == fa ace — o Neither the Securities and Exchange Commission nor any slate securities commission has approved or disapproved of these di ..... 0) ... = .- securities or passed upon the adequacy or accurac

any of our securities, in addition to the other information in this prospectus, you should carefully consider the risk factors contained in Part I, Item IA under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 and in our 2014 Annual Report to Sha